Lataa...
How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
Several randomized controlled trials of anti-estrogens, such as tamoxifen and aromatase inhibitors, have demonstrated up to a 50–65% decrease in breast cancerincidence among high-risk women. Approximately 15% of women, age 35–79 years, in the U.S. meet criteria for breast cancer preventive therapies...
Tallennettuna:
| Julkaisussa: | NPJ Breast Cancer |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group UK
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5460136/ https://ncbi.nlm.nih.gov/pubmed/28649660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-017-0021-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|